- Home
- JYD vs NXL Comparison
JYD vs NXL Comparison
Compare JYD & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYD
- NXL
- Stock Information
- Founded
- JYD 2001
- NXL 2010
- Country
- JYD China
- NXL United States
- Employees
- JYD N/A
- NXL N/A
- Industry
- JYD Oil Refining/Marketing
- NXL Medical Specialities
- Sector
- JYD Consumer Discretionary
- NXL Health Care
- Exchange
- JYD Nasdaq
- NXL Nasdaq
- Market Cap
- JYD 18.9M
- NXL 17.8M
- IPO Year
- JYD 2023
- NXL 2022
- Fundamental
- Price
- JYD $0.13
- NXL $1.86
- Analyst Decision
- JYD
- NXL Strong Buy
- Analyst Count
- JYD 0
- NXL 1
- Target Price
- JYD N/A
- NXL $5.00
- AVG Volume (30 Days)
- JYD 4.9M
- NXL 9.7M
- Earning Date
- JYD 10-24-2025
- NXL 11-07-2025
- Dividend Yield
- JYD N/A
- NXL N/A
- EPS Growth
- JYD N/A
- NXL N/A
- EPS
- JYD N/A
- NXL N/A
- Revenue
- JYD $77,444,271.00
- NXL $174,813.00
- Revenue This Year
- JYD N/A
- NXL $38.28
- Revenue Next Year
- JYD N/A
- NXL $185.71
- P/E Ratio
- JYD N/A
- NXL N/A
- Revenue Growth
- JYD 13.54
- NXL 16.42
- 52 Week Low
- JYD $0.09
- NXL $0.59
- 52 Week High
- JYD $8.00
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- JYD 39.38
- NXL 80.20
- Support Level
- JYD $0.12
- NXL $0.86
- Resistance Level
- JYD $0.16
- NXL $0.97
- Average True Range (ATR)
- JYD 0.02
- NXL 0.10
- MACD
- JYD -0.00
- NXL 0.05
- Stochastic Oscillator
- JYD 16.98
- NXL 69.87
About JYD Jayud Global Logistics Limited
Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, supply chain management, and other value-added services.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.